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Abstract
Purpose To compare in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) in regard to post-fertilization
development and outcome with the purpose of ascertaining the most effective fertilization method for assisted reproduction.
Methods A retrospective cohort study of 136 split IVF/ICSI cycles (where sibling oocytes are fertilized by two different methods
using the same sperm sample).
Results IVF-derived embryos developed to the blastocyst stage at a significantly faster rate than ICSI-derived embryos. There
was no significant difference in fertilization or livebirth rates between the two fertilization methods.
Conclusions For patients with sperm progressive motility ≥ 1.0 × 106/ml (who usually constitute the majority of patients), no
significant difference between the two fertilization methods was found in regard to fertilization rate or livebirth rate. Remaining
factors influencing choice between the two methods appear to be restricted to convenience, financial considerations and concern
with regard to possible perpetuation of genetically linked infertility to future generations.
Keywords IVF . ICSI . Embryo development
Introduction
In the field of assisted reproduction, the introduction of
intracytoplasmic sperm injection (ICSI) [16] has resulted in
a choice of fertilization method between conventional in vitro
fertilization by insemination (IVF) and fertilization by ICSI.
Fertilization by insemination calls upon functions of the sperm
that are bypassed by injection directly into the oocyte.
Therefore, the choice of the fertilization method for an indi-
vidual couple should largely depend upon the results of the
sperm analysis. Severe oligospermia (low sperm concentra-
tion), asthenozoospermia (low motility) or teratozoospermia
(abnormal morphology) indicate the use of ICSI. Another fac-
tor to be considered is the reproductive history of the couple.
Previous successes or failures using either IVF or ICSI are
obviously relevant to future treatment. In the case of IVF,
unexpected complete fertilization failure (CFF) in an individ-
ual cycle is a well-known phenomenon and is a risk to the
success of IVF cycles. Opinion is divided as to whether these
isolated occurrences necessitate the universal use of ICSI in
assisted reproduction. There remains much support for the
view that IVF has a role when the sperm analysis shows no
severe deficiencies and where there is no history of previous
CFF [2, 6, 9].
When there is uncertainty as to which fertilization method
to use, the option of split IVF/ICSI can be adopted. In this
method, approximately half of the sibling oocytes are random-
ly chosen to be fertilized by IVF and the remainder are fertil-
ized by ICSI. Comparing the fate of multiple oocytes from the
same cycle using the same sperm sample gives a valid com-
parison between fertilization methods, helping to plan the fu-
ture treatment of the couple.
Some relatively early studies [1, 11] used split cycles mainly
for the purpose of comparing IVF and ICSI fertilization rates,
giving much attention to their use as a safeguard against CFF. In
many cases, it may have been assumed that once the oocyte was
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fertilized, the method of fertilization ceased to be relevant.
However, the two fertilization methods are so different [12] that
the possibility of differences in outcome cannot be ignored. Vitek
et al. [22] compared the three different fertilization procedures:
all-IVF, all-ICSI and split IVF/ICSI and, in support of
Bhattacharya et al. [2], found no significant difference in fertili-
zation rate between IVF and ICSI. For a single cycle, split IVF/
ICSI and all-ICSI were each associated with a 3.0 percentage
higher livebirth rate when compared with all-IVF. The authors
reached the conclusion that, for a single cycle, all-ICSI was not
justified due to the higher cost per livebirth.
The present study aims, through the use of split IVF/ICSI
cycles, to explore the choice between the two main fertiliza-
tion methods with a view to finding whether or in what way
fertilization method affects post-fertilization embryo develop-
ment. Particular attention was given to rates of post-
fertilization development and livebirth outcome. A record
was kept of the history of each embryo, enabling comparison
of the state and outcome of embryos both before and after
transfer to the uterus.
Methods
Patients
This is a retrospective cohort study of the results of 136 split
IVF/ICSI cycles performed at the Centre for Reproduction
and Genetic Health (CRGH), London W1W 5QS between
2004 and 2018. The study was approved by the University
College London Ethics Committee, ethical approval number
05/Q0502/143. All 136 patients in the study gave written con-
sent and were attending the CRGH with problems of infertil-
ity. Each cycle included the transfer of either one or two fresh
embryos into the female patient’s uterus. Female patients were
< 43 years of age. All male patients had percentage motility ≥
27 and a sperm progressive motility concentration of ≥
1.0×10 6 /ml.
Couples who required gamete donation or cases where ei-
ther the male or female was found to have an abnormal blood
karyotype were excluded from the study.
Sperm preparation
After liquefaction and semen analysis, the semen sample was
centrifuged at 300g for 20 min in a 45% and 90% PureSperm
density gradient (Nidacon International, Gothenburg, Sweden).
Dilutions were made with fertilization medium (Quinn’s
Advantage Fertilization (HTF) Medium, CooperSurgical,
Trumbull, CT, USA). The pellet was washed twice with 10-
min centrifugation each time and suspended in fertilization me-
dium. The sperm concentration was determined, and the
suspension was kept in an incubator at 37 °C with a 6% carbon
dioxide atmosphere in preparation for IVF and ICSI.
IVF and ICSI procedures
The stimulation protocol has been described previously (Speyer
et al. 2010) [19].When at least two leading follicles reached the
diameter of 18mm, hCGwas administered by injection. Dishes
for oocyte culture were prepared on the day of hCG injection by
placing 0.5 ml of fertilization medium into each well of 5-well
Nunc dishes (Fisher Scientific UK Ltd., Loughborough, UK)
overlaid with 0.5 ml Ovoil (Vitrolife, Gothenburg, Sweden).
The dishes were kept at 37 °C with 6% CO2 to be ready for
oocyte retrieval, which was done 37 h after hCG. Each re-
trieved cumulus-oocyte complex was placed in the medium in
a well. The resulting wells were in two groups destined for IVF
and ICSI respectively. The numbers in the two groups were
made as equal as possible without discarding oocytes. In 82%
of cycles, the two numbers differed by only one oocyte.
IVF insemination
Incubation of the oocytes destined for IVF continued at 37 °C
and 6% CO2 before and after insemination, which was per-
formed 40 h after hCG. A volume of prepared sperm suspen-
sion sufficient to give a final concentration of 200,000 motile
sperm/ml was added to each well containing a cumulus-
oocyte complex. Incubation under the same conditions con-
tinued until 18–20 h after insemination, when fertilization
checks were done. Fertilized embryos were transferred to
SAGE 1-step medium with HSA and phenol red
(CooperSurgical) and incubated at 37 °C with 6% CO2.
ICSI insemination
Incubation of the cumulus-oocyte complexes in the wells of the
Nunc dishes was continued in fertilization medium until denu-
dation, which was done 41 h after hCG. Denudation was
achieved through the use of cumulase (CooperSurgical, USA).
ICSI was then done by standard procedures [5, 16]. The
prolonged incubation of the cumulus-oocyte complexes before
denudation gave the oocytes time tomature [23]. Even so, it was
found after denudation that a small percentage of oocytes (34
oocytes in total from 136 cycles) were still immature, and these
were termed Bpoorly maturing oocytes^. Since these oocytes
could not be fertilized they had to be discarded. A similar per-
centage of such oocytes was observed at the fertilization check
of the oocytes that had been subjected to the IVF insemination
process. Sperm-injected oocytes were placed into SAGE 1-step
medium with HSA and phenol red and incubated at 37 °C with
6% CO2. Fertilization checks were performed 15.5–17.5 h after
sperm injection. Incubation of fertilized embryos continued in
the SAGE medium.
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Comparison of the incubation stages of IVF and ICSI
Both methods started with retrieved oocyte-cumulus com-
plexes incubated in fertilization medium. In the case of IVF,
fertilization occurred in the same medium (beginning 40 h
after hCG) and ending at fertilization check (58–60 h after
hCG). Transfer of zygotes from fertilization medium to Sage
medium occurred at fertilization check. In the case of ICSI,
fertilization and transfer to SAGE medium both occurred 41 h
after hCG. With both methods, culture in SAGEmedium con-
tinued until optimum embryo development was reached
around days 3–7 after fertilization.
Embryo transfer
Either one or two embryos were transferred, depending upon
the fertility and informed wishes of the patient. Fertilized em-
bryos were carefully inspected at the time of optimum devel-
opment. The embryos for transfer were chosen according to
their grading quality and state. Blastocysts, where present,
were chosen for transfer rather than earlier stages of develop-
ment. Blastocysts were graded using the Cornell grading sys-
tem [14] and the best-quality ones chosen for transfer, regard-
less of whether they were originally from IVF or ICSI. This
meant that in some cases (mixed transfers), one IVF and one
ICSI embryo were transferred together. Any good-quality em-
bryos not required were cryopreserved for possible use in
subsequent freeze/thawed embryo transfers.
Statistics
The SPSS software version 24 was used for comparison of
means by independent samples t test. For non-normal data
(Tables 2 and 3) the Mann-Whitney test was used.
Results
Table 1 gives information on the 136 couples in the study, the
reasons for their infertility and the main features of their sperm
analyses. The diagnosis of male factor infertility was given if
the sperm analysis showed a sperm concentration of < 18
million/ml or a progressive motility of < 40%. Although it is
more usual to use only the ICSI method on male factor pa-
tients, use of a split cycle gives the chance of success to both
fertilization methods.
Table 2 shows mean fertilization rates for the 136 split
cycles. There was no significant difference between IVF and
ICSI in fertilization rate whether or not the cycles with com-
plete IVF fertilization failure (CFF) were omitted from the
calculation. The omission of these 4 cycles was found to
slightly increase the mean fertilization rate for ICSI as well
as increasing that for IVF. This is explained by the fact that
two of the 4 CFF cycles had a low (25% and 33%) fertilization
rate using ICSI. It was concluded that the sperm defect in these
two patients might be more extensive than in the other two
patients with CFF and affect fertilization by ICSI as well as by
IVF, and in fact, these two patients did not achieve a livebirth.
The other two CFF patients, with ICSI fertilization rates
66.7% and 85.7%, achieved respectively a singleton and a
twin livebirth. The 4 CFF cycles were included in the main
study except where stated otherwise.
It was of interest to investigate the fate of the fertilized
embryos in order to detect any effect of the mode of fertiliza-
tion upon subsequent outcomes such as suitability for embryo
transfer to the female patient. In each of the 136 cycles, the
best quality one or two embryos regardless of fertilization
method were transferred. For each cycle, the fertilization
method (or methods in the case of mixed transfers) of the
transferred embryos was recorded. It was found that in
61(44.9%) of the 136 cycles, the transferred embryos were
Table 1 Clinical data on patients
Data on patients
No. of couples 136
No. of cycles 136
Average female age (± SD) 35.0 (± 4.0)










Mean sperm conc. × 106/ml. (± SD) 31.4 (± 22.0)
Mean percentage motility (± SD) 55.3 (± 13.1)
Mean normal morphology 16.7 (± 12.4)
Table 2 Fertilization rates
Fertilization method Mean fertilization rate (%)
IVF 66.5 (± 25.8)
ICSI 64.1 (± 22.2)
IVF excluding CFF cycles 68.5 (± 23.4)
ICSI excluding CFF cycles 64.4 (± 22.0)
Mean fertilization rates. The total number of split IVF/ICSI cycles is 136
and the number of cycles with complete IVF fertilization failure (CFF) is
4. The difference P between IVF and ICSI fertilization rates was non-
significant regardless of whether or not the CFF cycles were included.
The Mann-Whitney test confirmed non-significance between fertilization
rates (P = 0.182)
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IVF-fertilized, in 41 cycles (30.1%) they were ICSI-fertilized
and in the remaining 34 cycles (25.0%) (mixed transfers) one
IVF-fertilized embryo and one ICSI-fertilized embryo were
transferred together. The difference between the numbers of
IVF-fertilized (61) and ICSI-fertilized (41), both out of 136
cycles, was significant by t test (P = 0.012).
In choosing embryos for transfer, it is the clinic’s policy to
transfer blastocysts in preference to morula- or cleavage-stage
embryos since they have been reported to yield higher pregnancy
rates [3, 10]. Therefore, the next step was to compare the total
numbers of IVF-derived and ICSI-derived blastocysts formed
during the period of blastocyst formation, which ended around
day 7 post-fertilization. The results are shown in Table 3. The
total numbers of blastocysts formed were non-significantly
higher for IVF fertilization (332) than for ICSI fertilization
(287). This lack of significance between the total numbers of
IVF-derived and ICSI-derived blastocysts formed raises the
question as to why was the number of cycles in which IVF-
fertilized embryos were transferred significantly higher than the
number of cycles in which ICSI-fertilized embryos were trans-
ferred? In this respect, the total numbers of blastocysts from all
136 cycles shown in Table 3 does not give a reliable indication of
the relative numbers of IVF-fertilized and ICSI-fertilized embry-
os transferred. The decisions as to which embryos to transfer
were dealt with one cycle at a time. In some cycles, a large
number of blastocysts were produced, and since only one or
two embryos were transferred, many blastocysts were cryopre-
served and lost to the calculation of total blastocyst number.
Other cycles had no blastocysts, and the decision was based on
the quality of less-developed embryos. Data on the embryos
actually transferred gives a more direct picture of the embryos
chosen for best developmental stage and quality, and this infor-
mation is shown in Table 4. The total number of embryos trans-
ferred was 228. Of these, the number selected to be transferred as
IVF-fertilized only or as ICSI-fertilized only was 94 and 66
respectively. The difference in numbers is significant (P =
0.006). If, instead of the number of embryos, we consider the
number of blastocysts, we see that Table 4 includes 80 IVF-
derived blastocysts, 51 ICSI-derived blastocysts, and 39 mixed
blastocysts. Of the mixed transferred blastocysts, 20 were IVF-
derived and 19 ICSI-derived. Including these blastocysts, the
total number of IVF-derived and ICSI-derived transferred blas-
tocysts respectively was 80 + 20 and 51 + 19, i.e. 100 and 70.
The difference between 100 and 70, both out of 228 is significant
(P = 0.004). In mixed transfers, the number of IVF-derived and
ICSI-derived embryos for each stage of development was equal
Table 3 Blastocyst formation in 136 split ivf/icsi cycles
IVF ICSI Significance P
Total number of embryos 665 611 NS




The total number of blastocysts formed after each fertilization method up
to and including the seventh day after fertilization. The Mann-Whitney
test confirmed non-significance between the number of blastocysts from
the two different fertilization rates (P = 0.202)
Table 4 Embryos transferred In 136 SPLIT IVF/ICSI cycles
Developmental stage IVF ICSI Mixed
Blastocysts 80 (85.1) 51 (77.3) 39 (57.4)
Morula 5 (5.3) 3 (4.5) 5 (7.4)
Pre-morula 0 (0) 2 (3.0) 4 (5.9)
Cleavage 9 (9.6) 10 (15.2) 20 (29.4)
Total 94 66 68
The cycles in the table are the 136 split IVF/ICSI cycles listed in Table 1. Figures in brackets are percentages of the totals. All 228 embryos in the table
were transferred. Either one or two embryos were transferred per cycle, depending upon the fertility and the informed wishes of the couple. The best
embryos available in each cycle with regard to developmental stage and quality were chosen for transfer. The options for transfer were (1) IVF-derived
embryos only, (2) ICSI-derived embryos only or (3) (mixed transfer) one IVF-derived embryo and one ICSI-derived embryo transferred together
In calculating the significant difference in the number of IVF-derived and ICSI-derived embryos transferred one can either omit or include the embryos of
the mixed transfers. Of these 68 mixed embryos, 34 were IVF-derived and 34 ICSI-derived. Of the 39 mixed blastocysts, 20 were IVF-derived and 19
ICSI-derived
(a) Calculations omitting mixed transfers
IVF-derived       ICSI-derived               Significance P
Embryos transferred       
(b) Calculations including mixed transfers
Embryos transferred                   
Blastocysts transferred
94 66 0.006
Blastocysts transferred 80 51    <0.001
128 100 0.046
100  70 0.004
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or close to equal. Total embryo count was 34 for each fertil-
ization method in the mixed column. The number of mor-
ulas was 2 for IVF-derived and 3 for ICSI-derived. Of the
20 mixed cleavage-stage embryos, 10 were derived from
each fertilization method. The high percentage of cleavage
stage embryos in the mixed column (Table 4) was associ-
ated with a relatively low level of livebirth events for this
column (Table 5).
The evidence from Table 4 indicates that the embryol-
ogists, in choosing one or two embryos for transfer to the
female patient’s uterus, chose IVF-derived blastocysts sig-
nificantly more often than they chose ICSI-derived blas-
tocysts. An experienced embryologist judged the best
time to carry out embryo transfer, which was when further
incubation was unlikely to result in quality improvement.
The preferred choice of IVF-derived blastocysts could be
explained if IVF-derived embryos developed faster to the
blastocyst stage than ICSI-derived embryos, yielding a
better choice of blastocyst at the time of embryo transfer.
To test this assumption, we counted the number of IVF-
derived and ICSI-derived blastocysts recorded on the day
of first blastocyst appearance. The 22 cycles in which
neither fertilization method produced blastocysts and also
the 27 cycles in which an equal number of IVF-derived
and ICSI-derived blastocysts were recorded on the day of
first blastocyst appearance were excluded from the
calculation of significance. The calculation was performed
firstly including the 4 CFF cycles and secondly excluding
the 4 CFF cycles (see Table 6). Recorded details of the
136 cycles were examined and the origin of each blasto-
cyst present on the day when the first blastocyst(s) ap-
peared was noted. Lists were made of cycles in which
IVF-derived blastocysts outnumbered ICSI-derived blas-
tocysts and of cycles in which ICSI-derived blastocysts
outnumbered IVF-derived blastocysts. Table 6 shows that
when the 4 CFF cycles were excluded from the calcula-
tion, there was a significant difference (P = 0.012) in fa-
vor of IVF-derived blastocysts (on the day in which blas-
tocysts were first observed) between the number of cycles
in which IVF-derived blastocysts predominated and the
number of cycles in which ICSI-derived blastocysts pre-
dominated. This indicates that under the conditions of the
study, there was a significant difference in favor of IVF-
derived embryos between IVF-derived and ICSI-derived
embryos in the rate of development to the blastocyst
stage. This observation explains the significantly greater
number of IVF-derived embryos transferred in the 136
IVF/ICSI cycles compared to the number of ICSI-
derived embryos. On the chosen day of transfer, IVF-
derived blastocysts may have been the only blastocysts
present or may have outnumbered ICSI-derived blasto-
cysts, making it likely that they were chosen for transfer.
Table 5 Outcomes from 136 split IVF/ICSI cycles
Origin of transferred embryos IVF-derived ICSI-derived Mixed
No. of cycles 61 41 34
No. of singleton live births 26 (42.6) 16 (39.0) 10 (29.4)
No. of twin live births 10 (16.4)* 10 (24.4)* 3 (8.8)
No. of biochemical pregnancies 4 (6.6) 2 (4.9) 4 (11.8)
No. of fetal heartbeat miscarriages 4 (6.6) 4 (9.8) ◊ 2 (5.9)
No. of negative pregnancy cycles 17 (27.9) 9 (22.0) 15 (44.1)
Total live birth events 36 (59.0) 26 (63.4) 13 (38.2)
Embryo transfers in the table were from the 136 split IVF/ICSI cycles listed in Table 1. The transferred embryos originated from one of 3 options: IVF-
derived only, ICSI-derived only, or the third option (mixed transfer) from one IVF-derived embryo together with one ICSI-derived embryo. The choice of
embryos to transfer was based on developmental stage and quality. Livebirth events are the sum of singleton and twin livebirths. Figures in brackets are
percentages of the totals. The differences between outcomes are as follows:
Total livebirth events (%) Significance P 
IVF-derived              v            ICSI-derived  
59.0                                     63.4                          0.470 Not significant
IVF-derived              v               mixed
59.0                                     38.2                          0.003 Significant
ICSI-derived             v               mixed   
63.4                                      38.2                       <0.001 Significant
*One of the IVF-derived twin livebirths originated in one sac and resulted from the transfer of one blastocyst only. Two of the ICSI-derived twin
livebirths and one of the IVF-derived twin livebirths each resulted from the transfer of two cleavage stage embryos
◊One of these was an ectopic pregnancy
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The outcomes of the cycles that received IVF-derived em-
bryos, ICSI-derived embryos and embryos from bothmethods
of fertilization (mixed transfers) are shown in Table 5. The
choice of whether to transfer one or two embryos to the patient
largely depended upon the fertility of the patient, the less
fertile patients being more likely to receive two embryos.
For this reason, the outcomes in Table 5 pay no regard to
whether one or two embryos were transferred. Statistical anal-
ysis showed no significant difference (P = 0.47) between total
live birth events (59% and 63.4%) derived from IVF and ICSI
fertilization respectively, although both were significantly
higher thanmixed transfers (P = 0.003 and < 0.001 respective-
ly). Thus, there is no significant evidence from the data in
Table 5 that either IVF or ICSI fertilization is superior to the
other in terms of producing a livebirth.
The question arises as to how to choose between IVF and
ICSI in situations where it may be inconvenient to carry out a
split cycle. Often, a value is set for concentration or motility
below which ICSI is always chosen as the fertilization method,
but this method is not ideal because cut-off points for IVF fer-
tilization need to be decided. The results from the present study
show that 7 IVF-derived livebirths resulted from patients whose
sperm concentration was 14–19 million per ml, and a frequent
cut-off point is 20 million per ml, which would have excluded
these IVF-derived livebirths, although theymight have occurred
if ICSI-derived embryos had been chosen for transfer.
Discussion
In each cycle, the decision had to be made as to which embry-
os should be transferred to the female patient’s uterus. This
was decided on the basis of the degree of development and
quality of each embryo in the cycle. The number of cycles in
which IVF-fertilized embryos were transferred was signifi-
cantly higher than the number of cycles in which ICSI-
fertilized embryos were transferred. This was especially no-
ticeable in the significantly higher number of IVF-fertilized
blastocysts transferred compared to the number of ICSI-
fertilized blastocysts. An explanation for these findings is that
in many cycles, the IVF-fertilized embryos were further ahead
in their development than were the ICSI-fertilized embryos,
and were therefore chosen for transfer. Shoukir et al. [17] also
found that the rate of blastocyst development was significantly
higher (47.3%) in IVF-derived embryos than the rate in ICSI-
derived embryos (26.8%). They state that the embryos obtain-
ed by IVF fertilization were of significantly better quality than
the embryos obtained by ICSI fertilization. In their discussion,
the authors review problems that may arise when abnormal
spermatozoa enter oocytes by the process of ICSI.
It might be expected that if the IVF-fertilized embryos had
a tendency to be more rapid in their development than the
ICSI-fertilized embryos, then the IVF-fertilized embryos
might also result in a higher percentage of livebirths, but in-
stead, the ICSI-fertilized embryos resulted in a non-
significantly higher percentage of livebirth events than the
IVF-fertilized embryos. It is interesting that two of the ICSI-
derived and one of the IVF-derived twin livebirths in Table 6
each resulted from the transfer of two cleavage-stage embryos.
These observations indicate that although ICSI-fertilized em-
bryos may have been slower to develop than the correspond-
ing IVF-fertilized embryos, once they had reached a certain
stage of development, they were competent in proceeding to
implantation and livebirth. Exactly what events in its devel-
opment give an embryo the ability to proceed to livebirth after
transfer to the uterus is uncertain. The 3 pairs of cleavage stage
embryos in the IVF-derived and ICSI-derived columns that
gave rise to 3 twin livebirths in this study comprised one 6-
cell, four 8-cell and one 9-cell embryo. This suggests that at
least 6 cells in the embryo may be obligatory for livebirth to
result but 8 cells give a better likelihood.
The finding that blastocyst transfer is usually more success-
ful than the transfer of embryos at earlier stages of develop-
ment [3, 10] was confirmed in this study. Mixed blastocysts
comprised only 57.4% of total mixed transferred embryos
(Table 4), whereas the percentage of blastocysts in IVF-
derived and ICSI-derived transferred embryos was 85.1 and
77.3% respectively. The significance of the difference be-
tween 57.4% and the IVF and ICSI percentages is < 0.001
and 0.003 respectively. The significantly smaller percentage
of blastocysts in the mixed transferred embryos compared to
the IVF-derived and ICSI-derived embryos could explain the
lower percentage of livebirth events from the mixed embryos
seen in Table 5. The 20 cleavage stage mixed embryos result-
ed in no twin livebirths and only 2 of the 10 singleton
livebirths in the mixed column. A pair of pre-morulas resulted






















136 51 36 0.051
CFF cycles
excluded
132 51 32 0.012
The table shows the effect on the significance of fertilization method of
adding 4 complete IVF fertilization failure cycles (CFF cycles) into a
group of 132 non-CFF split IVF/ICSI cycles. For each cycle, the recorded
number of IVF-derived and ICSI-derived blastocysts present on the day
of first blastocyst appearance was made. The table was constructed from
two lists of cycles, in the first of which the number of IVF-derived blas-
tocysts exceeded that of ICSI-derived blastocysts and in the second of
which the opposite occurred
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in one singleton livebirth, and the remaining 7 singleton
livebirths all resulted from blastocysts.
The advent of ICSI led to a number of studies comparing
post-fertilization outcomes from IVF- and ICSI-fertilized em-
bryos, some of which used sibling oocytes in split cycles as in
the present study. Two reports, Chiamchanya et al. [7] (who
used IVF at higher than the usual sperm concentration) and
Shveiky et al. [18] used split cycles, and both studies found no
significant difference in implantation rate or pregnancy rate
between IVF-derived and ICSI-derived embryos. Staessen
et al. [20], working with IVF/ICSI split cycles of 47 couples,
record that 42 h after fertilization, more ICSI-fertilized embry-
os than IVF-fertilized embryos had reached the 4-cell stage
(P < 0.001) and more IVF-fertilized embryos than ICSI-
fertilized embryos were left behind at the 2-cell stage (P <
0.02). Lemmen et al. [15] using a time-lapse monitoring sys-
tem supported this observation. The faster development of
ICSI-derived embryos is reported to last until the 5-cell [20]
or 6-cell [13] stage.
The evidence described in our present study, which indi-
cates that IVF-derived embryos develop faster than ICSI-
derived embryos to the blastocyst stage is based on the signif-
icantly greater number of IVF-derived blastocysts compared
to ICSI-derived blastocysts on the day when blastocysts were
first seen. This difference in development rate resulted in a
greater number of IVF-derived embryos available for transfer.
This situation applies to the later phase of embryo develop-
ment when the embryo has ceased to rely upon maternal tran-
scripts and is fully controlled by its own genome. This hap-
pens at a time between the four-cell and eight-cell embryo
stages [4, 21].
Many research studies have compared the two fertilization
methods having one set of patients for fertilization by IVF and
another set of patients, perhaps with poorer quality sperm, for
fertilization by ICSI. Care is needed in the interpretation of this
type of study, and it is important that the oocytes destined for
ICSI are allowed time in contact with their cumulus cells before
denudation [23]. These studies can yield useful information
however. Dumoulin et al. [8] carried out the widely used pro-
cedure of fertilizing couples with poor sperm by ICSI and cou-
ples with good-quality sperm by IVF. They found that fertili-
zation by injection with poor-quality sperm had no effect on
embryo development up to day 3 after fertilization (the time of
reliance on maternal transcripts). However, at later stages of
development, when the embryonic genome is in control, the
original injection with poor-quality sperm had a marked ad-
verse effect on embryo development. IVF-fertilized embryos
would probably be affected in the same way if an inferior sper-
matozoon had previously entered the oocyte. However, in the
case of IVF, competition between spermatozoa exists, and
better-quality spermatozoa are more likely to achieve fertiliza-
tion of an oocyte than those of lower quality. Thus even in split
cycles, where the same sperm sample is used for the IVF and
ICSI fertilizations, the IVF-fertilized embryos aremore likely to
receive a better quality spermatozoon, and their developmental
progress toward blastocyst formation would therefore proceed
more rapidly than that of the ICSI-fertilized embryos. The faster
development rate of the IVF-fertilized embryos might simply
be a matter of whether the spermatozoon is chosen by natural
events or by human participation.
This theory, that IVF-derived embryos are fertilized by
sperm superior to those fertilizing ICSI, has an advantage over
any attempt to explain the slower rate of blastocyst formation
by ICSI on proposed delays related to the ICSI process. The
superior-sperm theory explains why ICSI-derived embryos
start their development faster than IVF-derived embryos and
only become slower at the 5–6-cell stage when the male genes
fully participate in the genome [4, 13, 15, 20].
In this study, we found no significant difference be-
tween IVF and ICSI in either fertilization rate or livebirth
rate. However, the success of ICSI in equalling or exceed-
ing the livebirth rate from IVF, and (an observation exter-
nal to this paper) achieving livebirths when sperm pro-
gressive motility is close to zero, draws attention away
from possible or likely infertility in male offspring
resulting from its use. The continuing use of IVF where
indicated by the history, diagnosis and general situation of
the infertile couple is justified by considerations of con-
venience and expense and, most importantly, by its supe-
riority over ICSI in bequeathing ongoing fertility to future
generations.
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